Literature DB >> 30351249

Management of Biliary Strictures: State-of-the-Art Review.

Baljendra S Kapoor1, Giovanni Mauri1, Jonathan M Lorenz1.   

Abstract

Biliary strictures can be broadly classified as benign or malignant. Benign biliary strictures are most commonly iatrogenic in nature and are a consequence of hepatobiliary surgery. Cholangiocarcinoma and adenocarcinoma of the pancreas are the most common causes of malignant biliary obstruction. This article reviews state-of-the-art minimally invasive techniques used to manage these strictures. In addition, the roles of (a) recently introduced biodegradable biliary stents in the management of benign biliary strictures and (b) intraprocedural imaging and navigation tools, such as cone-beam CT, in percutaneous reconstruction of the biliary-enteric anastomosis are discussed. © RSNA, 2018 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2018        PMID: 30351249     DOI: 10.1148/radiol.2018172424

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  17 in total

Review 1.  MRI evaluation of bile duct injuries and other post-cholecystectomy complications.

Authors:  Shilpa Reddy; Camila Lopes Vendrami; Pardeep Mittal; Amir A Borhani; Courtney C Moreno; Frank H Miller
Journal:  Abdom Radiol (NY)       Date:  2021-02-12

2.  A Risk Prediction Model for Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis After Stent Insertion for Malignant Biliary Obstruction: Development and Validation.

Authors:  Zhifeng Fu; Jitao Song; Yilin Pi; Xianxin Sun; Maoning Liu; Zunlong Xiao; Jing Chen
Journal:  Dig Dis Sci       Date:  2022-08-22       Impact factor: 3.487

Review 3.  Percutaneous Management of Benign Biliary Strictures.

Authors:  Adam Fang; Il Kyoon Kim; Ifechi Ukeh; Vahid Etezadi; Hyun S Kim
Journal:  Semin Intervent Radiol       Date:  2021-08-10       Impact factor: 1.780

Review 4.  Advancements in Endoscopic Biliary Interventions by Gastroenterology.

Authors:  Aymen Almuhaidb; Dylan Olson; A Aziz Aadam
Journal:  Semin Intervent Radiol       Date:  2021-08-10       Impact factor: 1.780

Review 5.  Noninvasive Imaging Prior to Biliary Interventions.

Authors:  Roberta Catania; Anil K Dasyam; Frank H Miller; Amir A Borhani
Journal:  Semin Intervent Radiol       Date:  2021-08-10       Impact factor: 1.780

6.  Survival prediction for patients with malignant biliary obstruction caused by pancreatic cancer undergoing biliary drainage: the COMBO-PaS model.

Authors:  Hai-Feng Zhou; Jia-Lei Wang; Wei Yang; Chun Zhou; Yan Shen; Ling-Ling Wu; Zhong-Ling Pei; Wei-Zhong Zhou; Sheng Liu; Hai-Bin Shi
Journal:  Surg Endosc       Date:  2022-10-19       Impact factor: 3.453

7.  Absorbable stents for treatment of benign biliary strictures: long-term follow-up in the prospective Spanish registry.

Authors:  Miguel A De Gregorio; Eva Criado; Jose A Guirola; Enrique Alvarez-Arranz; Mercedes Pérez-Lafuente; Marta Barrufet; Maria D Ferrer-Puchol; Sandra Lopez-Minguez; Jose Urbano; Carlos Lanciego; Alexander Aguinaga; Antonio Capel; Maria D Ponce-Dorrego; Abel Gregorio
Journal:  Eur Radiol       Date:  2020-03-27       Impact factor: 5.315

8.  Efficacy of Biodegradable Polydioxanone and Polylactic Acid Braided Biodegradable Biliary Stents for the Management of Benign Biliary Strictures.

Authors:  Weixing Zhang; Fariha Kanwal; Muhammad Fayyaz Ur Rehman; Xinjian Wan
Journal:  Turk J Gastroenterol       Date:  2021-08       Impact factor: 1.555

9.  Radiomics Facilitates Candidate Selection for Irradiation Stents Among Patients With Unresectable Pancreatic Cancer.

Authors:  Hai-Feng Zhou; Yu-Qi Han; Jian Lu; Jing-Wei Wei; Jin-He Guo; Hai-Dong Zhu; Ming Huang; Jian-Song Ji; Wei-Fu Lv; Li Chen; Guang-Yu Zhu; Zhi-Cheng Jin; Jie Tian; Gao-Jun Teng
Journal:  Front Oncol       Date:  2019-09-27       Impact factor: 6.244

Review 10.  The Diagnostic Dilemma of Malignant Biliary Strictures.

Authors:  Robert Dorrell; Swati Pawa; Yi Zhou; Neeraj Lalwani; Rishi Pawa
Journal:  Diagnostics (Basel)       Date:  2020-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.